US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 20.200
  • +0.060+0.30%
Close Dec 13 16:00 ET
  • 20.200
  • 0.0000.00%
Post 16:01 ET
1.46BMarket Cap-168.33P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Kiniksa Pharmaceuticals International Q3 2024 Earnings Date

Currency:USDOct 29, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
111.60M
112.21M
+615.50K
Beat Est.
+66.45%
+67.37%
+0.55%
EPS
0.03
-0.18
-0.21
Miss Est.
+116.51%
+10.00%
-645.45%
Strong Buy

Dec 13, 2024

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals International Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data